Work

The carcinoma-specific epithelial glycoprotein-2 promoter controls efficient and selective gene expression in an adenoviral context

Year: 2005

Type: article

Source: Cancer Gene Therapy

DOI: 10.1038/sj.cgt.7700882

Authors: W M Gommans, S J van Eert, P M J McLaughlin, M C Harmsen, M Yamamoto, D T Curiel, H J Haisma, M G Rots

Institutions: University of Groningen, University Medical Center Groningen, University of Alabama at Birmingham, UAB Medicine

Language: English

Topic: Virus-based gene therapy research

Subfield: Genetics

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: National Institutes of Health, National Cancer Institute, National Institute of Diabetes and Digestive and Kidney Diseases, National Institute of Arthritis and Musculoskeletal and Skin Diseases

Awards: G2181498309, G3018957155, A NOVEL STRATEGY FOR OSTEOPOROSIS GENE THERAPY, Enhanced CRAd for Pancreatic Cancer, DENDRITIC CELL SPECIFIC VECTOR, G624418465, G8309085511, Enhanced CRAd for Esophageal Adenocarcinoma

OpenAlex ID: W2070640252

FWCI: 1.176

Cites: 36

Cited by: 10

Related to: 10